JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265096

Human GANC knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

GANC KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 11. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human GANC knockout HeLa cell line (AB265096)
  • Sanger seq

Unknown

Sanger Sequencing - Human GANC knockout HeLa cell line (AB265096)

Homozygous : 4 bp deletion in exon 11.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 11

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265096-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265096 Human GANC knockout HeLa cell line", "number":"AB265096-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265096-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265096-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265096-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265096 Human GANC knockout HeLa cell line", "number":"AB265096-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265096-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265096 Human GANC knockout HeLa cell line", "number":"AB265096-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265096-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265096 Human GANC knockout HeLa cell line", "number":"AB265096-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GANC
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The GANC gene encodes the enzyme Glucosidase Alpha Neutral C (GAN Glucosidase) also commonly known as neutral alpha-glucosidase C. It plays an important role in carbohydrate metabolism by hydrolyzing terminal non-reducing (14)-linked alpha-glucose residues to release alpha-glucose. The enzyme mass is approximately 106 kDa. GANC is widely expressed in human tissues with significant presence in the liver pancreas and intestine where it contributes to glucose homeostasis and nutrient absorption.
Biological function summary

This enzyme is important for carbohydrate digestion and glucose production. GANC is not known to form part of a larger protein complex but acts individually to catalyze the breakdown of polysaccharides and oligosaccharides. By converting these molecules into glucose it provides an immediate source of energy for cells thereby supporting cellular metabolism and overall organismal energy balance.

Pathways

The enzyme takes part in the carbohydrate metabolism pathway and the glycogen degradation pathway. These pathways are instrumental in energy production and storage management in cells. GANC works in conjunction with enzymes like glycogen phosphorylase and beta-amylase to regulate the conversion of stored glycogen into glucose ensuring proper energy supply during fasting and physical activity.

GANC associations include diabetes mellitus and glycogen storage disorders. Dysfunction or imbalance in GANC activity can lead to improper glucose regulation characteristic in diabetes where glucose metabolism is impaired. The enzyme collaborates with insulin and glucagon regulation mechanisms to maintain glucose homeostasis. In glycogen storage disorders improper degradation of glycogen can exacerbate energy supply issues highlighting the significance of GANC in maintaining normal glucose levels and metabolic functions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.<br>5. Once confluent passage into an appropriate flask at a density of 2x10<sup>4</sup> cells/cm<sup>2</sup>. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.</p>

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com